The term signe de cils was introduced in the late 19th century and is attributed to Achille Souques, one of the most prominent French neurologists of his time.1 This clinical observation reflects the ...

Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, FLAMINGO-01, which is evaluating Fast Track designated ...

NeuroTherapia has concluded its Phase IIa clinical trial of NTRX-07, an orally available molecule, for Alzheimer's disease ...

PHI Air Medical, a leading U.S. helicopter-based medical transport provider, today proudly announces that its Cedar Creek base is setting the gold standard in emergency medical care across Central ...

Georgia-Pacific's Brewton Containerboard and Alabama River Cellulose facilities donated a total of $500,000 to three rural hospitals in Alabama. The funding will help local hospitals provide critical ...

Unprecedented,” “remarkable” and “transformative” were just a few of the descriptives tossed out by Wall Street analysts in response to Revolution Medicines Inc.’s phase III readout, showing RAS ...

Findings suggest that regular physical activity and adequate sleep may lower dementia risk, emphasizing the need for evidence-based lifestyle guidelines.

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the 'Company”), a clinical-stage pharmaceutical company developing targeted ...

Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform ...

Dr. Daniels is a seasoned biotechnology executive with more than two decades of experience spanning clinical development, regulatory strategy, corporate operations, and business development. He most ...

An experimental drug designed to silence a gene strongly linked to Parkinson's disease has shown encouraging effects in a ...

Replimune Group, Inc. stock drops after a second FDA rejection for RP1 melanoma; cash runway <12 months. Click for more on ...